Clinical Trial Update: Intra-arterial Stem Cell Therapy for Patients With Chronic Limb Ischemia (CLI) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of intra-arterial stem cell therapy for chronic limb-threatening ischemia (CLI) conducted by UMC Utrecht has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gangrene
• Leg Ulcer
• Limb-threatening Ischemia
• Peripheral Artery Disease

Drugs mentioned

• Intra-arterial stem cell therapy

Snippet

Sponsor: UMC Utrecht | Conditions: Peripheral Vascular Diseases, Arterial Occlusive Diseases | Phase 1, Phase 2 | Status: COMPLETED